Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Salamanca
Clinical trial register · Spain

Clinical Trials in Salamanca, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Madrid 109 Barcelona 96 Pamplona 44 Seville 40 Badalona 33
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Janssen Research & Development, LLC29 University of Salamanca20 Novartis Pharmaceuticals17 AstraZeneca16 Instituto de Investigación Biomédica de Salamanca13 Clear sponsor filter
Site location
Madrid109 Barcelona96 Pamplona44 Seville40 Badalona33
All 68 locations
Target enrolment
to

Trials with a site in Salamanca

29 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Barcelona, Cáceres, Córdoba, Jerez de la Frontera, Madrid, Pamplona, Salamanca, Santander
2026-05-31
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Badalona, Barcelona, Granada, Madrid, Pozuelo de Alarcón, Salamanca, Usansolo, Valencia
2026-02-04
Recruiting
Janssen Research & Development, LLC
Phase 2
60
Badalona, Barcelona, Madrid, Pamplona, Salamanca, Santander, Seville
2025-10-03
By invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes
DrugsJNJ-75348780·JNJ-87801493·JNJ-80948543·Ibrutinib
Janssen Research & Development, LLC
Phase 1
120
Barcelona, Madrid, Pamplona, Salamanca
2024-12-30
Active, closed
Janssen Research & Development, LLC
Phase 1
17
Badalona, Barcelona, Madrid, Pamplona, Salamanca
2024-12-19
Recruiting
Janssen Research & Development, LLC
Phase 1
276
Barcelona, Salamanca
2024-12-04
Recruiting
Janssen Research & Development, LLC
Phase 2
210
Badalona, Barcelona, El Palmar, Jerez de la Frontera, Madrid, Pozuelo de Alarcón, Salamanca
2024-08-26
Active, closed
Janssen Research & Development, LLC
Phase 2
43
Madrid, Salamanca, Santander
2024-08-20
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Barcelona, Madrid, Pamplona, Pozuelo de Alarcón, Salamanca, Santander
2024-06-07
Active, closed
Janssen Research & Development, LLC
Phase 3
731
Alcorcón, Badalona, Barcelona, Manises, Salamanca, Santiago de Compostela, Seville, Villajoyosa
2024-03-09
Active, closed
Janssen Research & Development, LLC
Phase 1
70
Barcelona, Madrid, Pamplona, Salamanca
2023-12-06
Recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
NCT05652335Relapsed or Refractory Multiple Myeloma, Previously Treated Amyloid Light-chain (AL) Amyloidosis
DrugRamantamig
Janssen Research & Development, LLC
Phase 1
180
Badalona, Barcelona, Madrid, Pamplona, Salamanca
2022-11-22
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Badalona, Barcelona, Granada, Jerez de la Frontera, Madrid, Palma de Mallorca, Pozuelo de Alarcón, Salamanca
2022-10-25
Active, closed
Janssen Research & Development, LLC
Phase 1
74
Badalona, Madrid, Pamplona, Salamanca
2022-05-25
Recruiting
Janssen Research & Development, LLC
Phase 4
295
Pamplona, Salamanca
2022-03-09
Active, closed
Janssen Research & Development, LLC
Phase 2
151
Badalona, Barcelona, Madrid, Pamplona, Salamanca
2022-03-01
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Barcelona, Gijón, Las Palmas de Gran Canaria, Madrid, Palma, Pamplona, Pozuelo de Alarcón, Salamanca
2021-10-14
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Barcelona, L'Hospitalet de Llobregat, Madrid, Murcia, Pamplona, Salamanca, Santander, Seville
2021-08-19
Recruiting
Janssen Research & Development, LLC
Phase 1/2
420
Barcelona, Madrid, Pamplona, Salamanca, Seville, Valencia
2021-05-19
Recruiting
Janssen Research & Development, LLC
Phase 2
510
Badalona, Barcelona, Madrid, Murcia, Pamplona, Pozuelo de Alarcón, Salamanca, Santander
2021-02-01
Active, closed
Janssen Research & Development, LLC
Phase 1/2
228
Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Salamanca, Santander
2020-12-15
Active, closed
Janssen Research & Development, LLC
Phase 2
194
Badalona, Barcelona, Madrid, Pamplona, Pozuelo de Alarcón, Salamanca, Santander
2020-09-17
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Badalona, Barcelona, Madrid, Pamplona, Salamanca, Seville
2020-06-12
Active, closed
Janssen Research & Development, LLC
Phase 1
290
Barcelona, Madrid, Pamplona, Salamanca
2020-02-21
Active, closed
Janssen Research & Development, LLC
Phase 2
208
Pamplona, Salamanca
2019-11-07
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Barcelona, Madrid, Pamplona, Salamanca, Seville
2018-04-17
Active, closed
Janssen Research & Development, LLC
Phase 1
279
Badalona, Madrid, Pamplona, Pozuelo de Alarcón, Salamanca
2017-12-16
Active, closed
Janssen Research & Development, LLC
Phase 1
302
Badalona, Barcelona, Pamplona, Salamanca
2017-05-16
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Salamanca
2013-09-09
Rows per page Showing 1–29 of 29
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/salamanca

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 29 of those studies with a site in Salamanca that also match the filters currently applied.

How many clinical trials are recruiting in Salamanca?

10 of the 29 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 18 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Salamanca), 29 studies
PhaseStudiesRecruitingShare
Phase 110234.5%
Phase 39331%
Phase 27324.1%
Phase 1/2216.9%
Phase 4113.4%

Most active sponsors

Lead sponsors with the most studies (Salamanca)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC2910
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.